Summary of findings 2: PLD alone vs other conventional chemotherapy
Hand‐foot syndrome (grade ≥ 3) · recurrent platinum‐resistant EOC
It is very uncertain whether summary of findings 2: PLD alone changes hand‐foot syndrome (grade ≥ 3) compared with other conventional chemotherapy (very low certainty).
1 finding from 1 review
- Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer 2023 · Cochrane Headline outcomes onlyno estimate extracted6 studies · 2184 participantsVery low